In 2011, a workgroup consisting of American Society of Clinical Oncology (ASCO) and ONS members was convened to review feedback received since publication of the ASCO/ONS Standards for Safe Chemotherapy Administration in 2009 and to clarify the standards as needed. The most significant change is the decision to extend their scope to the inpatient setting. This [...]
Researchers studied 700 women who were being treated with aromatase inhibitors and found that within four years, 36% of them had dropped out of treatment because of the side effects. One in every 10 patients stopped the treatment within 24 months. The side effects that caused the women to stop taking their medication included lowered libido, weight gain, hot flashes, and severe pain in the joints.
A new study has found that a majority of children experience positive and negative personal and relationship changes one year after their sibling has died from cancer. The study is the first to examine changes in children after the death of a brother or sister from cancer from three different perspectives—mothers, fathers, and siblings—up to a year after the sibling has died.
Using a human papillomavirus test in conjunction with a traditional Pap test results in earlier detection of precancerous lesions than using a Pap test alone, according to a new study.
Patients with early-stage Hodgkin lymphoma who were treated with multidrug chemotherapy were more likely to be alive 12 years after treatment than patients who received the same chemotherapy plus radiation, according to a new study.